Aromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea
Status: SUSPENDED
Study type: OBSERVATIONAL
Conditions: Polymorphism|CYP19|Aromatase Inhibitor
Sponsor: Samsung Medical Center